alexa
Reach Us +3225889658
Thomas Liehr | OMICS International

Journal of Genetics and Genomes
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Thomas Liehr

Institute of Human Genetics, Jena University Hospital, Jena
Germany
Publications

Successful Management of Three Pregnancies Under Imatinib Treatment in a Chronic Myeloid Leukemia Patient: A Case Report and Review of the Literature

Background:Imatinib Mesylate (IM), the first tyrosine kinase inhibitor recommended for the treatment of Chronic Myeloid Leukemia (CML) patients with presence of Philadelphia chromosome (Ph), led to marked improvement in the survival of patients in all phases of disease. The incidence of CML associated with pregnancy is not that rare, however, patie... Read More»

Abdulsamad Wafa, Suher AL-Medani, Thomas Liehr, Faten Moassass and Walid AL-Achkar

Case Report: J Genet Genom 2017, 1: 111

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top